| LINE ITEM (USD / %) | FY 2025
FILED 2026-02-01 | FY 2024
FILED 2025-02-02 | FY 2023
FILED 2024-01-28 |
|---|---|---|---|
| Revenue (Total Sales) | $565.2M | $626.6M | $646.7M |
| YoY Revenue Growth % | -9.8% | -3.1% | — |
| Gross Profit | $301.6M | $308.5M | — |
| Gross Margin % | 53.4% | 49.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$10.2M | -$36.9M | -$9.6M |
| Operating Margin % | -1.8% | -5.9% | -1.5% |
| Net Income (GAAP) | -$16.4M | -$43.7M | -$9.9M |
| EBITDA (Normalized) | -$4.1M | -$30.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $24.2M | -$16.9M | $38.7M |
| Capital Expenditures (CapEx) | $7.6M | $8.3M | — |
| Free Cash Flow (FCF) | $16.6M | -$25.2M | $38.7M |
| FCF Margin % | 2.9% | -4.0% | 6.0% |
| Return on Invested Capital (ROIC %) | -5.3% | -16.2% | — |
| Cash & Short-Term Equivalents | $16.3M | $3.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $169.0M | $182.7M | — |